DrugPatentWatch Database Preview
Drugs in Development Information for Pixantrone
Join the DrugPatentWatch Referral Program Get access to a free drug patent landscape report or a free one-month subscription
What is the development status for investigational drug Pixantrone?
Pixantrone is an investigational drug.
There have been 18 clinical trials for Pixantrone.
The most recent clinical trial was a Phase 3 trial, which was initiated on July 1st 2004.
The most common disease conditions in clinical trials are Lymphoma, Lymphoma, Non-Hodgkin, and Lymphoma, B-Cell. The leading clinical trial sponsors are CTI BioPharma, Theradex, and Johannes Gutenberg University Mainz.
Summary for Pixantrone
| US Patents | 0 |
| International Patents | 0 |
| US Patent Applications | 2,345 |
| WIPO Patent Applications | 1,659 |
| Japanese Patent Applications | 1 |
| Clinical Trial Progress | Phase 3 (2004-07-01) |
| Vendors | 48 |
Recent Clinical Trials for Pixantrone
| Title | Sponsor | Phase |
|---|---|---|
| Study of Pixantrone in CD20+ Relapsed/Refractory Aggressive Non-Hodgkin Lymphoma | The Lymphoma Academic Research Organisation | Phase 2 |
| Dose-Escalation Study of Pixantrone Monotherapy in Pediatric Patients With Relapsed or Refractory Cancer | CTI BioPharma | Phase 1 |
| Phase 1/2 Study of the Combination of Pixantrone, Etoposide, Bendamustine and, in CD20 Positive Tumors, Rituximab in Patients With Relapsed Aggressive Non-Hodgkin Lymphomas of B- or T-cell Phenotype - the P[R]EBEN Study | University of Aarhus | Phase 1/Phase 2 |
Clinical Trial Summary for Pixantrone
Top disease conditions for Pixantrone
Top clinical trial sponsors for Pixantrone
US Patents for Pixantrone
| Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
|---|---|---|---|---|
| >Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
